Researchers find drugs with anti-prion activityCattleNetwork.comThe scientists found two drugs, tacrolimus and astemizole compounds that reduced the amount of the normal form of the prion protein (PrP) on cell surfaces by approximately 70 percent. Of t…
St. Mary's Episcopal Church's 125-year legacy – Main Line
|
St. Mary’s Episcopal Church’s 125-year legacy
Main Line That same year, parishioners dedicated the Good Friday offering to the St. Paul’s Negro and Indian School in Lawrenceville, Va., and paid the expenses for a parish Boy Scout to attend the Boy Scout Jubilee celebration. … A newspaper article in an … |
Statins Show Protective Effect Against Acute Kidney Injury – Renal and Urology News
Statins Show Protective Effect Against Acute Kidney InjuryRenal and Urology NewsInitiating a statin prior to coronary artery bypass grafting (CABG) surgery may modestly reduce the risk of acute kidney injury (AKI) post-CABG, especially in patients less…
changing customer behavior – Business Insider
changing customer behaviorBusiness InsiderWhen public health workers offered a small incentive to Indian mothers for taking their children to get vaccinations, they offset the cost (time-consuming trip) with a reward in the moment (a free bag of lentil…
Surveyed U.S. Neurologists Would Prescribe Biogen Idec's Tecfidera to 20 … – Sacramento Bee
|
Surveyed U.S. Neurologists Would Prescribe Biogen Idec’s Tecfidera to 20 …
Sacramento Bee Clinical data and the opinions of thought leaders interviewed by Decision Resources indicate that other emerging agents—Lemtrada, ocrelizumab and AbbVie/Biogen Idec’s daclizumab—have advantages in reducing ARR over Teva’s Copaxone, the … |
Surveyed US Neurologists Would Prescribe Biogen Idec's Tecfidera to 20 … – MarketWatch (press release)
 MarketWatch (press release) |
Surveyed US Neurologists Would Prescribe Biogen Idec’s Tecfidera to 20 …
MarketWatch (press release) Clinical data and the opinions of thought leaders interviewed by Decision Resources indicate that other emerging agents–Lemtrada, ocrelizumab and AbbVie/Biogen Idec’s daclizumab–have advantages in reducing ARR over Teva’s Copaxone, the … |
Oiling up immunity – WellBeing
Oiling up immunityWellBeingWhen a foreign substance enters your body B-cells respond to the foreign proteins by producing specific antibodies. Antibodies are complex proteins that are released into the blood and carried to the site of infection. B-cell…
Surveyed U.S. Neurologists Would Prescribe Biogen Idec's Tecfidera to 20 … – PR Newswire (press release)
|
Surveyed U.S. Neurologists Would Prescribe Biogen Idec’s Tecfidera to 20 …
PR Newswire (press release) Clinical data and the opinions of thought leaders interviewed by Decision Resources indicate that other emerging agents—Lemtrada, ocrelizumab and AbbVie/Biogen Idec’s daclizumab—have advantages in reducing ARR over Teva’s Copaxone, the … |
Blood test may help predict lung cancer risk – Times of India
 Times of India |
Blood test may help predict lung cancer risk
Times of India “Our study indicates male smokers with low levels of bilirubin are a high-risk group that can be targeted with smoking cessation help, low-dose spiral CT screening of their lungs and other preventive measures,” said senior author Xifeng Wu, M.D., Ph.D … |
Does heart `smell` food we eat? – Times of India
Times of IndiaDoes heart `smell` food we eat?Times of IndiaBut surprisingly, there is growing evidence that also the heart, the lungs and many other non-olfactory organs have these receptors. And once a food is eaten, its components move from the stoma…